Rizatriptan Tablet, Film Coated
Product Images NDC 50090-7747

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan (NDC 50090-7747). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907747)

Rizatriptan 10 mg film-coated tablets label from A-S Medication Solutions. The label includes storage instructions to keep at 68 to 77 degrees Fahrenheit, and package size detailing 18 tablets divided into three blister packs of six tablets each. It also notes the active ingredient as Rizatriptan Benzoate with an equivalent strength to 10 mg of Rizatriptan free base.*

FDA Label Image

Fig-5 (Rizatriptan Fct Figure 5)

A line graph comparing the percentage response over time between Rizatriptan Benzoate Orally Disintegrating Tablets and placebo. The x-axis represents hours post stage 2 dose (0.5 to 2.0 hours), and the y-axis shows percent with 95% confidence intervals. Rizatriptan shows a higher percentage response than placebo over time.*

FDA Label Image

1 (Rizatriptan Figure One)

A line graph showing the estimated probability of response over hours post-dose for Placebo and Rizatriptan Benzoate Tablets 5 mg and 10 mg. The x-axis represents hours post-dose from 0 to 2, and the y-axis represents the estimated probability of response from 0% to 100%. Data shows increasing response probabilities over time, with Rizatriptan 10 mg having the highest response rate, followed by Rizatriptan 5 mg, and then placebo.*

FDA Label Image

1 (Rizatriptan Figure Two)

A line graph showing the estimated probability of remediation or rescue over 24 hours post-dose, comparing placebo, Rizatriptan Benzoate Tablets 5 mg, and Rizatriptan Benzoate Tablets 10 mg. The x-axis represents hours post-dose, and the y-axis represents estimated probability (%) ranging from 0% to 100%. The graph illustrates higher probabilities for the Rizatriptan Benzoate 10 mg dose compared to 5 mg and placebo over time.*

FDA Label Image

1 (Rizatriptan Structure One)

Chemical structure of rizatriptan, showing the arrangement of atoms including a triazole ring, an indole moiety, and a benzoic acid group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.